| Trial ID: | L0982 |
| Source ID: | EUCTR2006-001774-24-GB
|
| Associated Drug: |
Doxycycline
|
| Title: |
INTESTINAL MICRO-ORGANISMS IN THE PATHOGENESIS OF NASH AND THE ROLE OF MODULATION OF ENTERIC BACTERIA IN TREATMENT. - Enteric bacteria and non alcoholic steatohepatitis
|
| Acronym: |
--
|
| Status: |
Authorised
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH)
|
| Interventions: |
<br>Product Name: Doxycycline<br>Product Code: Doxycycline<br>Pharmaceutical Form: Capsule, hard<br><br>
|
| Outcome Measures: |
Main Objective: To demonstrate whether a six week course of doxycycline will eliminate endotoxin from the blood of patients with NAFLD/NASH and reverse the insulin resistance seen in this condition.;Secondary Objective: ;Primary end point(s): 1. Eradication of systemic endotoxaemia.<br>2. Alterations in insulin resistancenan
|
| Sponsor/Collaborators: |
Newcastle u Tyne Hospitals NHS Trust
|
| Gender: |
All
|
| Age: |
nannan
|
| Phases: |
Not applicable
|
| Enrollment: |
40
|
| Study Type: |
Interventional clinical trial of medicinal product
|
| Study Designs: |
Controlled: no
Randomised: no
Open:
Single blind:
Double blind:
Parallel group:
Cross over:
Other:
If controlled, specify comparator, Other Medicinial Product:
Placebo:
Other:
|
| Start Date: |
18/09/2006
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 March 2012
|
| Locations: |
United Kingdom
|
| URL: |
https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-001774-24
|
